LANSING, MI--(Marketwire - October 19, 2010) - Kraig Biocraft Laboratories, Inc. (PINKSHEETS: KBLB) announced that the Company, working in cooperation with leading laboratories, is synthesizing DNA sequences and genetic constructs for its second generation of advanced spider silk based polymers. The artificial DNA constructs which the company is creating were specifically developed with the technical textiles market in mind.
“These new designer DNA sequences are being rolled out as a part of our plan to build on our recent success by creating new materials and new products,” said Kraig’s CEO Kim Thompson. “These new genetic constructs are being created right now, for use in the production of a new class of high performance fibers. We are developing this next generation of genetically modified silk fibers specifically to capture a share of the technical textiles market. This is the primary market for high strength fibers and is currently estimated at $120 billion. We believe that these revolutionary materials will have tremendous potential in the technical textiles marketplace for high strength fibers.”
“High strength designer fibers have the potential to satisfy the multi-billion dollar demand for new materials with tremendous strength-to-weight ratios,” Thompson continued. “Based upon what we learned in the process of developing our first generation of revolutionary fibers, we believe that these second generation designer DNA sequences have the potential to significantly increase raw strength-to-weight ratios.”
Kraig Biocraft Laboratories recently announced its scientific and commercial breakthrough in producing genetically engineered (recombinant) spider silk in a scalable and cost effective platform. The biotechnology company is a leader in the development of genetic engineering technologies with applications for the global textile markets.
A short video of the press conference in which the scientific and commercial breakthrough was announced can be seen at:
http://www.youtube.com/watch?v=GnUupDb2Mvo
For more information on Kraig Biocraft Laboratories, please visit the Company’s web site: www.KraigLabs.com
Statements in this press release about the company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plan,” “expects,” “anticipates,” “foresees,” “hopes,” “develops,” “developing,” “development” “researching,” “research,” “potential,” “seen,” “could” or other words or phrases of similar import. Similarly, statements in this release that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company’s financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.
Contact:
Ben Hansel
(720) 288-8495
Email Contact
